Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Cancer Prev Res (Phila). 2020 Jan 22;13(4):357–366. doi: 10.1158/1940-6207.CAPR-19-0496

Table 2.

Inhibition of Tumorigenesis by BRB in the oral cavity of DBP-treated mice.

Treatments
DBP DBP + BRB
Number of mice 30 30
CIS 4 (13.3)1 1 (3.3)
Papilloma 10 (33.3)1 4 (13.3)*
SCC 12 (40.0)1 10 (33.3)
Total Tumors 21 (70.0)2 14 (46.7)*
1

Number in parentheses, percentage of mice developed tumors.

2

Tumors induced by DBP in the oral cavity consist of papilloma, CIS and SCC.

*

Tumor incidence was significantly reduced compared to DBP treatment, p < 0.05.